CClinicalTrials.gg
CompletedNCT03123705EPBUpdated Oct 28, 2019

El Paso Public Health Biorepository

An observational study in Oral Disease and Bacterial Disease, sponsored by Texas Tech University Health Sciences Center, El Paso. Completed at 1 site in United States. Open to participants aged 10 Years to 21 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-10-28.

Sponsored by Texas Tech University Health Sciences Center, El Paso · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
90
Ages
10 Years to 21 Years
Sex
All
01

Study summary

The prevalence of tooth decay and other oral diseases are overlooked indicators of overall public health. To improve the understanding of oral health in El Paso, the City of El Paso Health Department will work with Texas Tech University Health Sciences Center at El Paso to determine factors that contribute to poor oral health, and lead to cavities and periodontitis. The team will collect saliva from children and young adults to study oral infections, markers of inflammation, and other contributors to oral illnesses in Mexican-American individuals.

Read the detailed description

As per summary above.

02

Conditions studied

  • Oral Disease
  • Bacterial Disease

Browse trials for

03

In context

Bacterial Infections

658 studies on the registry are indexed under Bacterial Infections; 100 are open to participants now.

This study's enrollment of 90 is below the median of 200 across 229 observational studies indexed under Bacterial Infections.

Browse Bacterial Infections studies →

Lead sponsor

Texas Tech University Health Sciences Center, El Paso is the lead sponsor of 43 studies on the registry; 3 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 2 (40%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
10 Years to 21 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Male and female patients between the ages of 10-21.

Inclusion criteria

  • Individuals seen at the City of El Paso dental or pediatric clinics ages 10-21
  • Healthy children and patients that are likely to be seen in the clinics within the predetermined follow-up time of 6 months

Exclusion criteria

Exclusion Criteria:

  • Patients under 10 years of age and over 21 years of age.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
90 participants (actual)
Patient registry
No
Biospecimen retention
Samples with dna
06

What researchers measure

Primary outcomes

  1. Creation of saliva bio-repository

    Saliva will be collected from dental patients to be stored for research

    Time frame: Through study completion, an average of 3 years

  2. The study of oral bacteria

    DNA of samples will be analyzed to determine if bacteria play a role in oral health

    Time frame: Through study completion, an average of 3 years

07

Study locations

1 site
  • Texas Tech University Health Sciences Center El Paso
    El Paso, Texas 79905, United States
08

References and documents

Individual participant data

Plan to share: Yes — De-identified information and tissue and body fluid samples will be made available to collaborating academic institutions through material transfer agreements.

Supporting information: Study protocol

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 28, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03123705
Lead sponsor
Texas Tech University Health Sciences Center, El Paso
Collaborators
The City of El Paso Department of Public Health
Responsible party
Peter Rotwein (Professor, Texas Tech University Health Sciences Center, El Paso) — Principal investigator
First posted
Apr 21, 2017
Start date
May 26, 2017
Primary completion
Aug 31, 2019
Completion
Sep 30, 2019
Last update
Oct 28, 2019

Study contacts

Peter S Rotwein, M.D.
principal investigator · Texas Tech University Health Sciences Center, El Paso

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion